Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

3373 reported adverse events

Drugs of this class: BEMPEDOIC ACID BEMPEDOIC ACID AND EZETIMIBE

These side effects are most commonly reported by patients taking drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class:

# Side effect Count
0 MYALGIA 468
1 ARTHRALGIA 315
2 PAIN IN EXTREMITY 208
3 MUSCLE SPASMS 207
4 NAUSEA 176
5 FATIGUE 172
6 DIZZINESS 168
7 HEADACHE 159
8 DIARRHOEA 151
9 PAIN 107
See all common reactions for Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

Drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REFUSAL OF VACCINATION 2 0.6667
1 ALPHA-2 MACROGLOBULIN INCREASED 1 0.1667
2 DIGESTIVE ENZYME DECREASED 1 0.0714
3 GLUCOSE URINE 9 0.0600
4 GASTROPARESIS POSTOPERATIVE 1 0.0588
5 CREATINE KINASE ABNORMAL 1 0.0417
6 RENAL HYPERTENSION 9 0.0289
7 LIPOPROTEIN (A) INCREASED 9 0.0275
8 BRACHIAL ARTERY ENTRAPMENT SYNDROME 1 0.0263
9 COMPUTERISED TOMOGRAM HEART ABNORMAL 2 0.0244
See all enriched reactions for Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]